BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7331277)

  • 1. [Methylprednisolone shock dose therapy of systemic lupus erythematosus with central nervous system involvement].
    Alekberova ZS; Folomeeva OM; Savinov VA; Berezova NIu
    Vopr Revm; 1981; (4):60-1. PubMed ID: 7331277
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system manifestations in juvenile systemic lupus erythematosus: a problem of management.
    Davies UM; Ansell BM
    J Rheumatol; 1988 Nov; 15(11):1720-1. PubMed ID: 3236306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].
    Ivanova MM; Bliziuk OI; Travkina IV
    Ter Arkh; 1995; 67(5):45-7. PubMed ID: 7638778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favourable outcome in a patient with central nervous system lupus.
    Bichile LS; Pruthi MS; Zarkar A; Sabnis SA
    J Assoc Physicians India; 1999 Dec; 47(12):1201-2. PubMed ID: 11225227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus cystitis in association with severe gastrointestinal manifestations in an adolescent.
    Dancey P; Constantin E; Duffy CM; Scuccimarri R
    J Rheumatol; 2005 Jan; 32(1):178-80. PubMed ID: 15630745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic lupus erythematosus with involvement of the central nervous system in childhood].
    Raith M; Raith L; Walch R; Wagner U
    Padiatr Grenzgeb; 1985; 24(5):415-22. PubMed ID: 4069715
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of acute cerebral lupus in childhood to pulse methylprednisolone in reduced dosage.
    Hanmer O; Saltissi D
    Ann Rheum Dis; 1986 Jul; 45(7):606-7. PubMed ID: 3740985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methylprednisolone pulse therapy for SLE patients with CNS disorder].
    Ichikawa Y; Hashimoto H; Kashiwazaki S; Kondo H; Akizuki M; Tokanou Y
    Ryumachi; 1994 Aug; 34(4):733-43. PubMed ID: 7974024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of systemic lupus erythematosus with various central and peripheral neurological disorders presenting with motor paralytic bladder as a major manifestation].
    Horiki T; Moriuchi J; Kouzuma R; Haida M; Watanabe S; Katsuoka Y; Ichikawa Y
    Ryumachi; 1995 Oct; 35(5):821-6. PubMed ID: 8594661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus.
    Wysenbeek AJ; Leibovici L; Zoldan J
    J Rheumatol; 1990 Dec; 17(12):1695-6. PubMed ID: 2084249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The one-and-a-half syndrome in systemic lupus erythematosus.
    Yiğit A; Bingöl A; Mutluer N; Taşçilar N
    J Neuroophthalmol; 1996 Dec; 16(4):274-6. PubMed ID: 8956164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative cerebral perfusion SPECT in systemic lupus erythematosus with severe central nervous involvement--before and after methylprednisolone pulse therapy.
    You DL; Tzen KY; Kao PF; Tsai MF
    J Neuroimaging; 1998 Jan; 8(1):55-7. PubMed ID: 9442596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elective involvement of the central nervous system in lupus erythematosus].
    Rompf G
    Fortschr Neurol Psychiatr Grenzgeb; 1971 May; 39(5):229-45. PubMed ID: 5206641
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultra-high (shock) doses of methylprednisolone in lupus nephritis].
    Solov'ev SK; Ivanova MM
    Ter Arkh; 1980; 52(4):121-3. PubMed ID: 7404327
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.
    García-Moreno JM; Chacón J
    Mov Disord; 2002 Nov; 17(6):1329-35. PubMed ID: 12465077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of systemic lupus erythematosis with high doses of cyclophosphamide].
    Baranowska-Daca E
    Wiad Lek; 1993 Nov; 46(21-22):868-71. PubMed ID: 7817583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system manifestations after pulse therapy for systemic lupus erythematosus.
    Ayoub WT; Torretti D; Harrington TM
    Arthritis Rheum; 1983 Jun; 26(6):809-10. PubMed ID: 6860385
    [No Abstract]   [Full Text] [Related]  

  • 18. Central nervous system involvement in systemic lupus erythematous.
    Johns Hopkins Med J; 1981 Oct; 149(4):140-2. PubMed ID: 7289345
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulse cyclophosphamide for severe neuropsychiatric lupus.
    Boumpas DT; Yamada H; Patronas NJ; Scott D; Klippel JH; Balow JE
    Q J Med; 1991 Dec; 81(296):975-84. PubMed ID: 1808642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus.
    Gallo M; La Montagna G; Chianese U; Tirri R; Tirri G
    J Rheumatol; 1992 Aug; 19(8):1322-3. PubMed ID: 1404179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.